If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
SUZHOU, China, June 1, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing ...
A phase II study of bevacizumab (BEV) plus erlotinib (ERL) in patients with gemcitabine (GEM)-refractory metastatic pancreatic cancer (MPC) No significant financial relationships to disclose. This is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback